Lea Ann Dailey Biography
Lea Ann Dailey is a pharmacist by training and completed her PhD at the Philipps University of Marburg, Germany, on the topic of biocompatibility testing of polymeric nanoparticles for the controlled release of drugs in the lung. She continued working in the field of formulation science for inhalation therapies at Nektar Therapeutics (now Novartis, San Carlos, CA, USA), followed by positions at King’s College London, UK, the Martin Luther University Halle-Wittenberg, Germany, and the University of Vienna. Her research has focussed on the design of dosage forms for the delivery of anti-infectives to the lung as well as the biocompatibility assessment of novel excipients for inhaled products.
David Harris Biography
David is passionate about improving the lives and wellbeing of patients and has focused his 25+ year career on the development of medical devices, mainly in the field of respiratory drug delivery.
As a physicist he enjoys the complex and challenging science that underpins inhalation – and has applied his knowledge that has led to over 60 patent applications in the field, many of which are commercially successful products.
As Chief Technology Officer for Cambridge Healthcare Innovations he oversees the technical development of new devices and products.